302 related articles for article (PubMed ID: 19933335)
1. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.
Chiu IM; Phatnani H; Kuligowski M; Tapia JC; Carrasco MA; Zhang M; Maniatis T; Carroll MC
Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20960-5. PubMed ID: 19933335
[TBL] [Abstract][Full Text] [Related]
2. In Vivo imaging reveals distinct inflammatory activity of CNS microglia versus PNS macrophages in a mouse model for ALS.
Dibaj P; Steffens H; Zschüntzsch J; Nadrigny F; Schomburg ED; Kirchhoff F; Neusch C
PLoS One; 2011 Mar; 6(3):e17910. PubMed ID: 21437247
[TBL] [Abstract][Full Text] [Related]
3. Very Early Involvement of Innate Immunity in Peripheral Nerve Degeneration in SOD1-G93A Mice.
Angelini DF; De Angelis F; Vacca V; Piras E; Parisi C; Nutini M; Spalloni A; Pagano F; Longone P; Battistini L; Pavone F; Marinelli S
Front Immunol; 2020; 11():575792. PubMed ID: 33329541
[TBL] [Abstract][Full Text] [Related]
4. Counteracting roles of MHCI and CD8
Nardo G; Trolese MC; Verderio M; Mariani A; de Paola M; Riva N; Dina G; Panini N; Erba E; Quattrini A; Bendotti C
Mol Neurodegener; 2018 Aug; 13(1):42. PubMed ID: 30092791
[TBL] [Abstract][Full Text] [Related]
5. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis.
Graber DJ; Hickey WF; Harris BT
J Neuroinflammation; 2010 Jan; 7():8. PubMed ID: 20109233
[TBL] [Abstract][Full Text] [Related]
6. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
[TBL] [Abstract][Full Text] [Related]
7. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis.
Nguyen MD; D'Aigle T; Gowing G; Julien JP; Rivest S
J Neurosci; 2004 Feb; 24(6):1340-9. PubMed ID: 14960605
[TBL] [Abstract][Full Text] [Related]
8. Progressive Degeneration and Inhibition of Peripheral Nerve Regeneration in the SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis.
Deng B; Lv W; Duan W; Liu Y; Li Z; Ma Y; Zhang G; Song X; Cui C; Qi X; Li Y; Li C
Cell Physiol Biochem; 2018; 46(6):2358-2372. PubMed ID: 29742495
[TBL] [Abstract][Full Text] [Related]
9. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.
Chiu IM; Chen A; Zheng Y; Kosaras B; Tsiftsoglou SA; Vartanian TK; Brown RH; Carroll MC
Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17913-8. PubMed ID: 18997009
[TBL] [Abstract][Full Text] [Related]
10. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.
Butovsky O; Siddiqui S; Gabriely G; Lanser AJ; Dake B; Murugaiyan G; Doykan CE; Wu PM; Gali RR; Iyer LK; Lawson R; Berry J; Krichevsky AM; Cudkowicz ME; Weiner HL
J Clin Invest; 2012 Sep; 122(9):3063-87. PubMed ID: 22863620
[TBL] [Abstract][Full Text] [Related]
11. Immune reactivity in a mouse model of familial ALS correlates with disease progression.
Alexianu ME; Kozovska M; Appel SH
Neurology; 2001 Oct; 57(7):1282-9. PubMed ID: 11591849
[TBL] [Abstract][Full Text] [Related]
12. Immune response in peripheral axons delays disease progression in SOD1
Nardo G; Trolese MC; de Vito G; Cecchi R; Riva N; Dina G; Heath PR; Quattrini A; Shaw PJ; Piazza V; Bendotti C
J Neuroinflammation; 2016 Oct; 13(1):261. PubMed ID: 27717377
[TBL] [Abstract][Full Text] [Related]
13. IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1.
Gravel M; Béland LC; Soucy G; Abdelhamid E; Rahimian R; Gravel C; Kriz J
J Neurosci; 2016 Jan; 36(3):1031-48. PubMed ID: 26791230
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: a role for wild-type superoxide dismutase 1 in sporadic disease?
D'Arrigo A; Colavito D; Peña-Altamira E; Fabris M; Dam M; Contestabile A; Leon A
J Mol Neurosci; 2010 Jul; 41(3):404-15. PubMed ID: 20177826
[TBL] [Abstract][Full Text] [Related]
15. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
16. scAAV9-VEGF-165 inhibits neuroinflammatory responses and invasion of macrophages into the peripheral nervous system of ALS transgenic mice.
Wang Y; Liu Y; Zhai J; Duan W; Sun S; Cui H; Chen X; Ji J; Liu Y
Brain Res Bull; 2018 Jun; 140():233-242. PubMed ID: 29751031
[TBL] [Abstract][Full Text] [Related]
17. The accumulation of enzymatically inactive cuproenzymes is a CNS-specific phenomenon of the SOD1
Hilton JB; Kysenius K; White AR; Crouch PJ
Exp Neurol; 2018 Sep; 307():118-128. PubMed ID: 29906423
[TBL] [Abstract][Full Text] [Related]
18. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
[TBL] [Abstract][Full Text] [Related]
19. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
20. Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Guo YS; Wu DX; Wu HR; Wu SY; Yang C; Li B; Bu H; Zhang YS; Li CY
Exp Mol Med; 2009 Mar; 41(3):140-50. PubMed ID: 19293633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
